Your session is about to expire
← Back to Search
tapinarof cream, 1% for Atopic Dermatitis
Study Summary
This trial is testing a new cream for atopic dermatitis (a skin condition). The cream will be compared to a placebo cream to see if it is more effective and safe.
- Atopic Dermatitis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 3 trial • 763 Patients • NCT04053387Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Please list the number of healthcare facilities where this experiment is taking place.
"Presently, this clinical trial is enrolling patients at 77 sites. The locations of these clinics are situated in cities such as Knoxville, Dallas and Garden City. If you choose to enroll in the trial, it would be helpful to select a clinic nearest to your home to limit travel requirements."
Has the FDA acknowledged tapinarof cream, 1% as a safe medication?
"There is enough evidence from both Phase 3 trials as well as other data sources to support the safety of tapinarof cream, 1%."
How many individuals are included in this clinical trial?
"The clinical trial is actively recruiting participants, with the most recent update on 1/28/2022. The posting for the trial was 9/1/2021. They are looking for 400 participants between 77 sites."
Are the results of this tapinarof cream study in line with other research?
"There are five ongoing studies involving tapinarof cream, 1%. Of these clinical trials, four are in Phase 3. The city of Rogers, Arkansas has the most medical centres running these tests; however, there are a total of 232 locations across the world conducting these experiments."
Are you currently looking for participants in this research?
"That is correct. The website clinicaltrials.gov has the most recent information regarding this study, which shows that it is presently recruiting patients. This trial was first posted on September 1st, 2021 and was last edited on January 28th, 2022. There are 77 sites enrolling 400 participants in total."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger